Blood-Based Biomarker Testing for Alzheimer’s Gets Formal Guidance
The Alzheimer's Association released its first clinical practice guideline on the use of blood-based biomarker tests.
The Alzheimer's Association released its first clinical practice guideline on the use of blood-based biomarker tests.
Alamar Biosciences has expanded its NULISAseq CNS Disease Panel 120 to include highly sensitive, blood-based assays.
A video game test may help detect Alzheimer's years before symptoms appear, offering a non-invasive alternative to blood tests.
Research suggests that mouth bacteria may influence memory and cognitive function, some promoting brain health while others risk Alzheimer’s.
Read MoreNeurocode USA Inc. published a study showing that its ALZpath pTau217 assay outperforms the Fujirebio assay in detecting Alzheimer’s disease.
Read MoreThe use of the PrecivityAD2 blood biomarker test significantly improved clinicians’ confidence in diagnosing Alzheimer’s disease.
Read MoreThe FDA granted Breakthrough Device Designation to Beckman Coulter’s Access p-Tau217/β-Amyloid 1-42 plasma ratio blood test.
Read MoreA new expert-led paper highlights the potential of biomarker testing to improve early diagnosis and treatment of synucleinopathies.
Read MoreNew guidelines for limbic-predominant age-related TDP-43 encephalopathy aim to differentiate the memory-loss syndrome from Alzheimer’s.
Read MoreDeclining blood levels of acetyl-L-carnitine and free carnitine are closely linked to Alzheimer’s severity, with sex-specific differences.
Read MoreSpear Bio’s pTau 217 blood test, a less-invasive solution for early Alzheimer’s diagnosis, received an FDA Breakthrough Device Designation.
Read MoreResearchers have visualized the atomic-level structure of protein clumps linked to Huntington’s disease, paving the way for diagnostic tools.
Read MoreThis episode of Clinical Lab Chat covers the how and why of making precise clinical diagnosis of neurodegenerative diseases.
Read MoreTwo universities are conducting a validation study on a blood test designed to detect early neurodegeneration in Alzheimer’s disease.
Read MoreA new study demonstrates the clinical utility of a skin biopsy diagnostic tool in improving care for those with neurodegenerative diseases.
Read MoreResearchers identified a promising blood biomarker for detecting vascular contributions to cognitive impairment and dementia.
Read MoreBlood-based diagnostics for Alzheimer’s disease and other neurological conditions could be here sooner than you think.
Read MoreResearchers explored how combining CSF analysis and amyloid PET imaging can improve the accuracy and efficiency of Alzheimer’s diagnosis.
Read More